Centene Corporation, a Fortune 50 company, is a leading multi-national healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Centene focuses on long-term growth and the development of its people, systems and capabilities so that it can better serve its members, providers, local communities, and government partners.
Company profile
Ticker
CNC
Exchange
Website
CEO
Michael Neidorff
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
ABC Network & Collaborative Health Systems Joint Venture, LLC • Absolute Total Care, Inc • AcariaHealth Pharmacy #11, Inc • AcariaHealth Pharmacy #12, Inc • AcariaHealth Pharmacy #13, Inc • AcariaHealth Pharmacy #14, Inc • AcariaHealth Pharmacy #26, Inc • AcariaHealth Pharmacy, Inc • AcariaHealth Solutions, Inc. • AcariaHealth, Inc. ...
IRS number
41406317
CNC stock data
Analyst ratings and price targets
Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
24 Mar 23
DEF 14A
Definitive proxy
24 Mar 23
10-K
2022 FY
Annual report
21 Feb 23
8-K
Centene Corporation Reports 2022 Results
6 Feb 23
8-K
Centene Corporation Announces 2023 Guidance
15 Dec 22
8-K
Centene Corporation Announces Leadership Changes and Appointments for Next Phase of Growth
14 Dec 22
8-K
Departure of Directors or Certain Officers
16 Nov 22
8-K
Centene Corporation Reports Third Quarter 2022 Results
24 Oct 22
10-Q
2022 Q3
Quarterly report
24 Oct 22
8-K
Amendments to Articles of Incorporation or Bylaws
30 Sep 22
Transcripts
CNC
Earnings call transcript
2022 Q4
7 Feb 23
CNC
Earnings call transcript
2022 Q3
25 Oct 22
CNC
Earnings call transcript
2022 Q2
26 Jul 22
CNC
Earnings call transcript
2022 Q1
26 Apr 22
CNC
Earnings call transcript
2021 Q4
9 Feb 22
CNC
Earnings call transcript
2021 Q3
26 Oct 21
CNC
Earnings call transcript
2021 Q2
27 Jul 21
CNC
Earnings call transcript
2021 Q1
27 Apr 21
CNC
Earnings call transcript
2020 Q4
9 Feb 21
CNC
Earnings call transcript
2020 Q3
27 Oct 20
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 12.33 bn | 12.33 bn | 12.33 bn | 12.33 bn | 12.33 bn | 12.33 bn |
| Cash burn (monthly) | 961.67 mm | 73.67 mm | 94.00 mm | (no burn) | 525.33 mm | (no burn) |
| Cash used (since last report) | 2.86 bn | 219.21 mm | 279.72 mm | n/a | 1.56 bn | n/a |
| Cash remaining | 9.47 bn | 12.11 bn | 12.05 bn | n/a | 10.77 bn | n/a |
| Runway (months of cash) | 9.8 | 164.4 | 128.2 | n/a | 20.5 | n/a |
Institutional ownership, Q4 2022
92.5% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 842 |
| Opened positions | 122 |
| Closed positions | 96 |
| Increased positions | 297 |
| Reduced positions | 307 |
| 13F shares | Current |
|---|---|
| Total value | 41.70 tn |
| Total shares | 509.90 mm |
| Total puts | 3.38 mm |
| Total calls | 1.69 mm |
| Total put/call ratio | 2.0 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 65.26 mm | $5.35 tn |
| Capital World Investors | 49.81 mm | $4.08 tn |
| BLK Blackrock | 40.67 mm | $3.34 tn |
| FMR | 29.12 mm | $2.39 tn |
| STT State Street | 24.75 mm | $2.03 tn |
| T. Rowe Price | 23.37 mm | $1.90 tn |
| Wellington Management | 20.37 mm | $1.67 tn |
| JPM JPMorgan Chase & Co. | 13.89 mm | $1.13 tn |
| Politan Capital Management | 13.11 mm | $1.08 tn |
| Boston Partners | 10.25 mm | $838.06 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 17 Mar 23 | Sarah London | Common Stock | Buy | Acquire P | No | No | 62.6 | 30,000 | 1.88 mm | 313,953 |
| 17 Mar 23 | James E Murray | Phantom Stock Phantom Stock | Grant | Acquire A | No | No | 63.19 | 27.39 | 1.73 k | 145.397 |
| 15 Mar 23 | Katie Casso | Common Stock | Grant | Acquire A | No | No | 63.34 | 14,209 | 900.00 k | 52,569 |
| 15 Mar 23 | Katie Casso | Common Stock | Payment of exercise | Dispose F | No | No | 63.34 | 809 | 51.24 k | 38,360 |
| 15 Mar 23 | Sarah London | Common Stock | Grant | Acquire A | No | No | 63.34 | 217,082 | 13.75 mm | 561,035 |
| 15 Mar 23 | Koster Christopher | Common Stock | Grant | Acquire A | No | No | 63.34 | 41,444 | 2.63 mm | 177,517.15 |
| 15 Mar 23 | James E Murray | Common Stock | Grant | Acquire A | No | No | 63.34 | 67,099 | 4.25 mm | 202,853 |
| 15 Mar 23 | James E Murray | Common Stock | Payment of exercise | Dispose F | No | No | 63.34 | 466 | 29.52 k | 135,754 |
News
Wells Fargo Maintains Equal-Weight Rating for Centene: Here's What You Need To Know
21 Mar 23
Meta Platforms To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Tuesday
21 Mar 23
Wells Fargo Maintains Equal-Weight on Centene, Lowers Price Target to $71
21 Mar 23
10 Health Care Stocks Whale Activity In Today's Session
16 Mar 23
(CNC) - Analyzing Centene's Short Interest
13 Mar 23
Press releases
Health Net Providing Special Assistance to Members Affected by Winter Storms
29 Mar 23
Evolent Health and Centene Agree to Expanded Partnership for Oncology Specialty Care for Medicare Advantage Members
29 Mar 23
CENTENE CORPORATION ANNOUNCES NEW CHIEF PEOPLE OFFICER
27 Mar 23
Health Net Providing Special Assistance to Members Affected by Winter Storms
17 Mar 23
Canada Nickel Demonstrates Robust Nickel Recoveries at the Reid Ultramafic Nickel Project, Announces Closing of Texmont Acquisition
15 Mar 23